Background: Hypertriglyceridemia (HTG) is postulated to be a rare cause of acute pancreatitis accounting for approximately 4% of causes. A serum triglyceride (TG) level above 1,000 mg/dl in the setting of pancreatitis and absent of other major causes is necessary to describe hypertriglyceridemia as a cause of acute pancreatitis. The mechanism involves the degradation of triglycerides by pancreatic lipase to release free fatty acids that induces free radical damage to the tissues. The major cornerstone in management is by reducing the triglyceride level to below 1000 mg/dL to achieve both the subsidal of the ongoing attack and the effective prevention of further episodes of pancreatitis. This can be achieved by a spectrum of treatment modalities ranging from includes dietary restriction of fat, administration of lipid-lowering agents to Experiences with plasmapheresis and effective lipid pharesis however, the latter modality hasn't been sufficiently discussed regarding therapeutic effects.